• Publications
  • Influence
Transradial versus transfemoral intervention for acute myocardial infarction: a propensity score-adjusted and -matched analysis from the REAL (REgistro regionale AngiopLastiche dell'Emilia-Romagna)
OBJECTIVES This study sought to assess whether transradial intervention, by minimizing access-site bleeding and vascular events, improves outcomes in patients with ST-segment elevation myocardialExpand
  • 99
  • 6
  • PDF
Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock.
OBJECTIVES The mortality of patients with cardiogenic shock (CS) complicating ST elevation acute myocardial infarction (STEMI) remains high, despite early revascularization. Current knowledge ofExpand
  • 86
  • 5
Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).
OBJECTIVES To evaluate the superiority of the paclitaxel-eluting stent (PES) in reducing neointimal hyperplasia (NIH) over its corresponding bare metal stent (BMS) during primary percutaneousExpand
  • 64
  • 3
Clinical expression of coronary artery ectasia
Objective Coronary artery ectasia (CAE) is an uncommon finding at cardiac catheterisation. Our objective was to retrospectively assess the angiographic prevalence of CAE and its clinical expression.Expand
  • 35
  • 2
Evidence for the existence of a functional cardiac renin-angiotensin system in humans.
BACKGROUND The presence of mRNA for the essential components of the renin-angiotensin system (RAS) has been found in animal and human hearts. The present study was designed to provide evidence forExpand
  • 83
  • 1
Myocardial stunning associated with a myocardial bridge.
A myocardial bridge is a discrete systolic constricnormal and tests for viral infections screened negation of a coronary artery, most commonly the left tive. She received oral aspirin (100 mg daily)Expand
  • 33
  • 1
  • PDF
In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry.
The in-hospital management of patients on warfarin undergoing coronary stent implantation (PCI-S) is variable, and the in-hospital outcome incompletely defined. To determine the adherence to theExpand
  • 16
  • 1
Left ventricular support device for cardiogenic shock during myocardial infarction due to stent thrombosis: a single centre experience.
BACKGROUND Stent thrombosis (ST) is a new, rare, cause of STEMI. Few data are available about incidence and clinical impact of shock complicating acute myocardial infarction due to ST (st-STEMI). Expand
  • 5
  • 1
A brief history of coronary interventional cardiology.
  • 3
  • 1
Safety and efficacy of the AngioJet in patients with acute myocardial infarction: results from the Florence Appraisal Study of Rheolytic Thrombectomy (FAST).
OBJECTIVES To assess the safety and efficacy of the AngioJet coronary device, given the uncertain risk-benefit balance of rheolytic thrombectomy in patients with acute myocardial infarction (AMI). Expand
  • 16